Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vaxcyte (PCVX) Other Non Operating Income (2019 - 2026)

Vaxcyte (PCVX) has 8 years of Other Non Operating Income data on record, last reported at -$1.4 million in Q1 2026.

  • On a quarterly basis, Other Non Operating Income fell 119.36% to -$1.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $28.8 million, a 478.57% increase, with the full-year FY2025 number at $37.3 million, up 953.23% from a year prior.
  • Other Non Operating Income reached -$1.4 million in Q1 2026 per PCVX's latest filing, down from $1.3 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for PCVX hit a ceiling of $28.6 million in Q2 2025 and a floor of -$47.0 million in Q4 2023.
  • A 5-year average of -$244588.2 and a median of $235000.0 in 2022 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: plummeted 598.42% in 2024, then soared 6044.73% in 2025.
  • Tracing PCVX's Other Non Operating Income over 5 years: stood at $11.2 million in 2022, then crashed by 518.06% to -$47.0 million in 2023, then soared by 75.83% to -$11.4 million in 2024, then surged by 111.65% to $1.3 million in 2025, then tumbled by 204.3% to -$1.4 million in 2026.
  • Business Quant data shows Other Non Operating Income for PCVX at -$1.4 million in Q1 2026, $1.3 million in Q4 2025, and $291000.0 in Q3 2025.